key: cord-1036683-8ub6clkp
authors: Langhi, Dante Mário; de Souza, Ricardo Cartaxo Modesto; Barros, Melca; de Santis, Gil Cunha; Kashima, Simone Haddad; Bordin, Jose Orlando
title: SARS-COV-2: Is It a Risk for Blood Transfusion?
date: 2021-09-01
journal: Hematol Transfus Cell Ther
DOI: 10.1016/j.htct.2021.08.001
sha: 91dfd2210c128e0a7f33585c5145a52e59283693
doc_id: 1036683
cord_uid: 8ub6clkp

nan

Dante Mário Langhi a,* 

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human coronavirus responsible for the coronavirus disease 2019 (COVID-19). The pandemic stage, has raised concerns about the possible risk that it might be transmissible by transfusion. This theoretical risk is further supported by reports of the detection of viral RNA in the blood of some infected individuals. Some studies suggest that some individuals who are eligible to donate blood are infected with SARS-CoV-2 but are asymptomatic/pre-symptomatic. Furthemore, the data suggest that very few of these asymptomatic/pre-symptomatic individuals are RNAemic. [1] [2] [3] Here we report on two cases of patients who received platelets and red blood cells transfusions from an individual who was infected with SARS-CoV-2.

A blood donation occurred on May 3, 2020. The blood donor presented with headache, cough, nasal congestion and runny nose on May 7, the day on which she was tested for SARS-CoV-2 by PCR of naso-oropharyngeal swabs (Veri-Q Prep M-16 extraction kit and Veri-Q PCR 316 detection kit). A day later, on May 8, she was informed that her test was positive and she notified the blood bank. The platelets and the red cell had been transfused into two distinct patients (patient 1 and patient 2). The plasma was discarded ( Figure 1) .

The blood sample was tested later by PCR (SARS-CoV-2 RNA extraction was performed on 300 µL of sera using the Extracta kit AN viral (Loccus) in an automated extractor (EXTRACTA 32, Loccus) following the manufacturer guidelines. The SARS-CoV-2-RT-PCR was conducted by Center for Disease Control (CDC) N1, N2 and RNAseP genes. The reaction protocol was performed using the GoTaq Probe 1-Step RT-qPCR System (Promega) according to the CDC protocol on the 7500 Real Time PCR System (Thermo Fisher Scientific). Cycles and temperatures for amplification were 30 minutes at 450°C for reverse transcription, followed by 45 cycles at 95°C for 2 minutes, 95°C for 15 seconds and 60°C for 1 minute. For all reactions, negative and positive controls were added.

The interpretation was made by the threshold cycle (Ct) and was negative. 

A 20-year-old pregnant woman was admitted to the hospital in labor on May 2, 2020 and the childbirth occurred on the following day. The patient was kept hospitalized, presenting bleeding due to the childbirth. On May 7, a day before the notification from the blood donor, she received a red cell transfusion from the same blood donor that tested positive for SARS-CoV-2. She was discharged from the hospital on May 9.

On May 14, 16 and 18, she was subjected to SARS-CoV-2 testing by PCR with naso-oropharyngeal swabs (Veri-Q Prep M-16 extraction kit and Veri-Q PCR 316 detection kit). The first and the last PCR tests were negative, and the second test was inconclusive. The ELISA tests for COVID-19 (Architect® SARS-CoV-2 IgG assay (Abbott) and Elecsys® Anti-SARS-CoV-2 -Roche) were both reactive. The blood PCR (described above) was negative ( Figure 3 ).

To date, the patient has not become symptomatic. As stated by Katz, 6 given that some asymptomatic/pre-symptomatic individuals appear to be infectious (through their respiratory secretions) and that some of these individuals must have donated blood since the beginning of the pandemic, if indeed SARS-CoV-2 were hematogenous, then it is likely that some cases of transmission by transfusion would have been identified among transfused patients on a worldwide scale.

On the other hand, to this day, there has not been a single reported case of donating blood for at least 28 days after the resolution of their symptoms. 9 

Post-donation COVID-19 identification in blood donors

Severe acute respiratory syndrome coronavirus 2 RNA detected in blood donations

COVID-19 transmission and blood transfusion: a case report

First results of the GRAAPH-2005 study in younger adult patients with de novo Philadelphia positive acute lymphoblastic leukemia

The SARS-CoV-2 outbreak: what we know

Is SARS-CoV-2 transfusion transmitted? Transfusion

SARS-CoV-2 viral load predicts COVID-19 mortality

Emerging infectious disease agents and their potential threat to transfusion safety. Appendix 2. SARS coronavirus

The authors have no conflict of interest to declare.